AmerisourceBergen drug co pays $625 mill. to settle charges of repackaging cancer drugs and 3 whistleblowers to share $93 million

AmerisourceBergen Corporation and its subsidiaries have agreed to pay $625 million to settle charges  that improperly repackaged oncology-supportive injectable drugs into pre-filled syringes and improperly distributed those syringes to physicians treating vulnerable cancer patients. Last year, AmerisourceBergen Specialty Group, a wholly-owned subsidiary of AmerisourceBergen Corporation, pled guilty to illegally distributing misbranded drugs...
Continue reading…

AstraZeneca pays $110 million to Texas to settle whistleblower charges of false marketing of antispychotic Seroquel and statin Crestor

Pharmaceutical company AstraZeneca will pay $110 million to the state of Texas to settle lawsuits alleging that the company falsely and misleadingly marketed two of its drugs in violation of the Texas Medicaid Fraud Prevention Act. AstraZeneca was accused of engaging in false and misleading marketing schemes at a time when the company was...
Continue reading…
shopping cart with receipts

New Year, New Drug Prices for Consumers

Several Pharmaceutical Companies Started 2018 by Increasing Drug Prices Big Pharma rang in the New Year by having customers ring up higher drug prices at the checkout counter.  According to Stat News, several big-name drug makers hiked prices up nearly 10%. Allergan (AGN) upped the price...
Continue reading…